For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Deferiprone | 75-100 mg/kg/day seven days per week Deferiprone: Deferiprone 80 mg/mL oral solution | 0 | None | 13 | 193 | 152 | 193 | View |
| Deferasirox | 20 to 40 mg/kg/day seven days per week Deferasirox: Deferasirox is used at the following dosage strengths: 125 mg, 250 mg and 500 mg | 0 | None | 14 | 197 | 89 | 197 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| testicular injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | testicular injury | View |
| splenectomy | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | splenectomy | View |
| agranulocytosis | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | agranulocytosis | View |
| neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | neutropenia | View |
| sickle cell anaemia with crisis subjects affected/exposed | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | sickle cell anaemia | View |
| seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | seizure | View |
| pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | pyrexia | View |
| chest pain | SYSTEMATIC_ASSESSMENT | General disorders | chest pain | View |
| gait disturbance | SYSTEMATIC_ASSESSMENT | General disorders | gait disturbance | View |
| diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | diarrhoea | View |
| hypertransaminasaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | hypertransaminasaemi | View |
| acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | acute kidney injury | View |
| pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | pain in extremity | View |
| gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | gastroenteritis | View |
| meningitis meningococcal | SYSTEMATIC_ASSESSMENT | Infections and infestations | meningitis meningoco | View |
| herpangina | SYSTEMATIC_ASSESSMENT | Infections and infestations | herpangina | View |
| pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | pneumonia | View |
| subcutaneous abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | subcutaneous abscess | View |
| urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | urinary tract infect | View |
| herpes virus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | herpes virus infecti | View |
| impetigo | SYSTEMATIC_ASSESSMENT | Infections and infestations | impetigo | View |
| upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | upper respiratory tr | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | cough | View |
| neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| abdominal pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| vomiting | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| pharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |